In the past year, Gelteq Ltd made $50,000 in revenue but faced a net loss of $2.3 million. The company has a market capitalization of $47.2 million.
Gelteq Pty Ltd described itself for its IPO as follows: “We are a science-based company focused on developing gel delivery solutions for prescription drugs, nutraceuticals, and pet care. Based in Australia, our products are often rebranded by other companies. We primarily make edible gels across five areas: pets, sports, pharmaceuticals, over-the-counter products, and nutraceuticals. Our patent-pending gels allow for multiple ingredients and wide applications. We aim to license our technology for companies to create new products, while continuing to sell our existing offerings under ‘white label’ agreements.”
* As of June 30, 2022, Gelteq Ltd reported a net loss of $2.29 million on roughly $100,000 in revenue.* Current figures are in US dollars. *For June 30, 2023, the company reported a net loss of $2.28 million on $50,000 in revenue.*
*Geltech Ltd is offering 1.3 million Class A ordinary shares at $5.00 to raise $6.5 million, as noted in their F-1 filing dated Aug. 30, 2022. They’re listing on NASDAQ.*
Founded in 2018, Gelteq Pty Ltd has 8 employees. The company is located at 100 Albert Road, South Melbourne, VIC, 3025, Australia. Contact them at +61 3 9087 3990 or visit http://www.gelteq.com.
Get Daily News & Ratings for Gelteq Ltd – Enter your email below to receive a daily summary of the latest news and ratings for Gelteq Ltd and related companies with MarketBeat.com’s FREE daily email newsletter.
`
